The DOI matches its Crossref record.
Epstein-Barr Virus Latent Gene Expression in Primary Effusion Lymphomas Containing Kaposi's Sarcoma–Associated Herpesvirus/Human Herpesvirus-8
Open accessAbstract
Primary effusion (body cavity–based) lymphoma (PEL) is a recently recognized subtype of malignant lymphoma that exhibits distinctive clinical and biological features, most notably its usual infection with the Kaposi's sarcoma–associated herpesvirus (KSHV). The vast majority of cases also contain Epstein-Barr virus (EBV). This dual viral infection is the first example of a consistent dual herpesviral infection in a human neoplasm and provides a unique model to study viral interactions. We analyzed the pattern of EBV latent gene expression to determine the pathogenic role of this agent in PELs. We examined five PELs coinfected with EBV and KSHV by reverse transcription-polymerase chain reaction (RT-PCR), in situ hybridization, and immunohistochemistry. EBER1 mRNA, a consistent marker of viral latency, was positive in all PEL cases, although at lower levels than in the non-PEL controls due to EBER1 expression by only a variable subset of lymphoma cells. Qp-initiated mRNA, encoding only EBNA1 and characteristic of latencies I and II, was positive in all PEL cases. Wp- and Cp-initiated mRNAs, encoding all EBNAs and characteristic of latency III, were negative in all cases. LMP1 mRNA, expressed in latencies II and III, was present in three cases of PEL, although at very low levels that were not detectable at the protein level by immunohistochemistry. Low levels of LMP2A mRNA were detected in all cases. BZLF1, an early-intermediate lytic phase marker, was weakly positive in four cases, suggesting a productive viral infection in a very small proportion of cells, which was confirmed by ZEBRA antigen expression. Therefore, PELs exhibit a restricted latency pattern, with expression of EBNA1 in all cases, and low LMP1 and LMP2A levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications
Jost, P. J., & Ruland, J. (2007) · Blood · doi:10.1182/blood-2006-07-025809 · Cited by 408
Cotter, M. A., & Robertson, E. S. (1999) · Virology · doi:10.1006/viro.1999.9999 · Cited by 349
RETRACTED: KSHV vFLIP Is Essential for the Survival of Infected Lymphoma Cells
Guasparri, I., Keller, S. A., & Cesarman, E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031467 · Cited by 324
Self-citationRetractedInhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells
Keller, S. A., Schattner, E. J., & Cesarman, E. (2000) · Blood · doi:10.1182/blood.v96.7.2537 · Cited by 315
Self-citationNakamura, H., Lu, M., Gwack, Y., Souvlis, J., Zeichner, S. L., & Jung, J. U. (2003) · Journal of Virology · doi:10.1128/jvi.77.7.4205-4220.2003 · Cited by 300
Metadata
- Authors
- Horenstein, M. G., Nador, R. G., Chadburn, A., Hyjek, E. M., Inghirami, G., Knowles, D. M., & Cesarman, E.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1997-08-01
- Volume
- 90
- Issue
- 3
- Pages
- 1186-1191
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2311728349
- Cited by
- 198
- References
- 0
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epstein-Barr Virus Latent Gene Expression in Primary Effusion Lymphomas Containing Kaposi's Sarcoma–Associated Herpesvirus/Human Herpesvirus-8. https://app.cochat.ai/papers/10.1182/blood.v90.3.1186
- The paper
- Horenstein, M. G., Nador, R. G., Chadburn, A., Hyjek, E. M., Inghirami, G., Knowles, D. M., & Cesarman, E. (1997). Epstein-Barr Virus Latent Gene Expression in Primary Effusion Lymphomas Containing Kaposi's Sarcoma–Associated Herpesvirus/Human Herpesvirus-8. Blood. https://doi.org/10.1182/blood.v90.3.1186
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.